ADN circulant libre était associé au score AFP (p=0.05, OR= 0.34 [IC95% : 12.87;348.71]). La figure 3 montre que les patients avec un score AFP >2 ,
Global cancer statistics, CA: A Cancer Journal for Clinicians, vol.82, issue.19 suppl, pp.69-90, 2011. ,
DOI : 10.3322/caac.20107
Hepatocellular carcinoma, The Lancet, vol.362, issue.9399, pp.1907-1924, 2003. ,
DOI : 10.1016/S0140-6736(03)14964-1
Estimates of the worldwide incidence of 25 major cancers in 1990, International Journal of Cancer, vol.64, issue.6, pp.827-868, 1999. ,
DOI : 10.1002/(SICI)1097-0215(19990315)80:6<827::AID-IJC6>3.0.CO;2-P
Primary liver cancer: Worldwide incidence and trends, Gastroenterology, vol.127, issue.5, pp.5-16, 2004. ,
DOI : 10.1053/j.gastro.2004.09.011
Global cancer statistics, CA: A Cancer Journal for Clinicians, vol.49, issue.1, pp.74-108, 2002. ,
DOI : 10.3322/canjclin.49.1.33
Hepatocellular carcinoma, Nature Reviews Disease Primers, vol.21, p.16018, 2016. ,
DOI : 10.1038/nrdp.2016.18
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference, Journal of Hepatology, vol.35, issue.3, pp.421-451, 2001. ,
DOI : 10.1016/S0168-8278(01)00130-1
Hepatocellular Carcinoma From Epidemiology to Prevention: Translating Knowledge into Practice, Clinical Gastroenterology and Hepatology, vol.13, issue.12, pp.2140-51, 2015. ,
DOI : 10.1016/j.cgh.2015.08.014
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4618036
Detectability of Hypervascular Hepatocellular Carcinoma by Arterial Phase Images of MR and Spiral CT, Acta Radiologica, vol.36, issue.4, pp.372-378, 1995. ,
DOI : 10.3109/02841859509173391
Hepatocellular carcinoma : A comprehensive review, World J Hepatol, vol.7, pp.2648-63, 2015. ,
Liquid Biopsies: Genotyping Circulating Tumor DNA, Journal of Clinical Oncology, vol.32, issue.6, pp.579-86, 2014. ,
DOI : 10.1200/JCO.2012.45.2011
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4820760
Controversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinoma, World Journal of Gastroenterology, vol.22, issue.1, pp.262-74, 2016. ,
DOI : 10.3748/wjg.v22.i1.262
Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma, Journal of Hepatology, vol.56, issue.1, pp.167-75, 2012. ,
DOI : 10.1016/j.jhep.2011.04.026
Free DNA in the serum of cancer patients and the effect of therapy, Cancer Res, vol.37, pp.646-50, 1977. ,
About the possible origin and mechanism of circulating DNA, Clinica Chimica Acta, vol.313, issue.1-2, pp.139-181, 2001. ,
DOI : 10.1016/S0009-8981(01)00665-9
Apoptotic markers in cancer, Clinical Biochemistry, vol.37, issue.7, pp.605-622, 2004. ,
DOI : 10.1016/j.clinbiochem.2004.05.003
Detection of circulating tumor DNA in early-and late-stage human malignancies, Sci Transl Med, vol.6, p.224, 2014. ,
Circulating cell-free DNA as a predictive marker for distant metastasis of hepatitis C virus-related hepatocellular carcinoma, British Journal of Cancer, vol.28, issue.10, pp.1399-403, 2007. ,
DOI : 10.1038/sj.bjc.6604034
Value of circulating cell-free DNA in diagnosis of hepatocelluar carcinoma, World Journal of Gastroenterology, vol.19, issue.20, pp.3143-3149, 2013. ,
DOI : 10.3748/wjg.v19.i20.3143
Circulating DNA level is negatively associated with the long-term survival of hepatocellular carcinoma patients, World Journal of Gastroenterology, vol.12, issue.24, pp.3911-3914, 2006. ,
DOI : 10.3748/wjg.v12.i24.3911
Clinical value of chip-based digital-PCR platform for the detection of circulating DNA in metastatic colorectal cancer, Digestive and Liver Disease, vol.47, issue.10, pp.884-90, 2015. ,
DOI : 10.1016/j.dld.2015.05.023
Cell-free DNA in the blood as a solid tumor biomarker???A critical appraisal of the literature, Clinica Chimica Acta, vol.411, issue.21-22, pp.1611-1635, 2010. ,
DOI : 10.1016/j.cca.2010.07.032
Liver Transplantation for Hepatocellular Carcinoma: A Model Including ??-Fetoprotein Improves the Performance of Milan Criteria, Gastroenterology, vol.143, issue.4, pp.986-94, 2012. ,
DOI : 10.1053/j.gastro.2012.05.052
URL : https://hal.archives-ouvertes.fr/inserm-00865368
Elevated levels of circulating cell-free DNA in the blood of patients with hepatitis C virusassociated hepatocellular carcinoma, Anticancer research, vol.26, pp.4713-4720, 2006. ,
Cell-free DNA: measurement in various carcinomas and establishment of normal reference range, Clinica Chimica Acta, vol.321, issue.1-2, pp.77-87, 2002. ,
DOI : 10.1016/S0009-8981(02)00091-8
Dosage and characterization of circulating DNA: present usage and possible applications in systemic autoimmune disorders, Autoimmunity Reviews, vol.2, issue.1, pp.50-55, 2003. ,
DOI : 10.1016/S1568-9972(02)00101-5